Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/13/2009 First Published: 5/11/2006


1.		Phase III Randomized Study of Zoledronate in Preventing Osteoporosis and Associated Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiotherapy and Luteinizing Hormone-Releasing Hormone Agonist Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				NCI				RTOG-0518 0518, NCT00329797


2.		Chemoprevention of Colorectal Adenomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				40 to 75				Pharmaceutical / Industry				COLO CP-01-US NCT00486512

Last Modified: 9/3/2008 First Published: 4/21/2006


3.		Phase II Randomized Study of Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				UMN-2005NT018 UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932

Last Modified: 5/20/2008 First Published: 7/6/2007


4.		Phase II Study of Cholecalciferol and Soy Supplementation in Patients With Biochemically Recurrent Prostate Cancer Following Failed Definitive Local Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Over 18				NCI				CCCWFU-85106 CCCWFU-IRB00000371, CCCWFU 85106, NCT00499408

Last Modified: 7/23/2008 First Published: 8/27/2007


5.		Phase II Randomized Study of Different Doses of Cholecalciferol (Vitamin D) in Patients With Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				RPCI-I-95406 I 95406, NCT00524680


6.		Vitamin D Effects on Prostate Pathology

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				30 to 85				Other				M2140 NCT00741364


7.		Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Diagnostic, Treatment				Active				18 and over				Other				07-0580-B NCT00744549


8.		Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				18 and over				Other				SUNY UMU IRB # 4689 NCT00145704

First Published: 10/23/2007


9.		Study of 24-Hydroxylase (CYP24) Single Nucleotide Polymorphisms and Splicing Variants That Modulate Vitamin D Metabolism and Serum Pharmacokinetics in Patients With Colorectal Cancer Receiving Cholecalciferol Supplementation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Supportive care, Treatment				Active				18 and over				NCI				RPCI-I-99207 I 99207, NCT00550563

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute